SOURCE: InoLife Technologies Inc.

November 24, 2014 08:00 ET

INOL Announces Launch of Kumi Discovery Campaign

BANNER ELK, NC--(Marketwired - Nov 24, 2014) - InoLife Technologies Inc., (PINKSHEETS: INOL) announced the roll out of a new line of products which will be under the brand name of Kumi. This line of products will be in the multi-billion dollar skin care and anti-aging industry. The products are produced and developed through a strategic alliance with an ISO 9001:2008 & ISO 14001(2004) accredited pharmaceutical company and WHO GMP certified for all its products and is specialized in the manufacturing of Cephalosporins and its intermediates. The Kumi discovery campaign kicks off with the launch of www.kumiproducts.com

Transform will be the inaugural product in the Kumi Brand line. Transform as all Kumi products will include not only the anti-aging solution but also the Confident Beauty Lifestyle coaching. Kumi is seeking to spread a restorative message along with unique skin and health products. This message will help women experience a fundamental shift in direction and purpose as it pertains to the concept of beauty. The Kumi website www.kumiproducts.com will combine a storefront approach with a restorative lifestyle education message.

InoLife CEO Gary Berthold stated "We are proud to escalate our product development to bring to market some of the finest products in the anti-aging skin care industry. Our relationship will provide a unique opportunity for a dramatic growth in this dynamic industry."

In the coming weeks InoLife Technologies will be releasing information on pricing and packaging of Transform the first product in the Kumi brand line.

InoLife Technologies, Inc. markets the commercial use of proprietary Intellectual Property by manufacturing, brand marketing and selling an integrated program of age reversing creams and lotions. These products will be sold directly to consumers through e-commerce, direct sales, pharmacies, retailers, distributors and healthcare providers. It also offers products that are sold only to physicians, hospitals, outpatient facilities and others in the medical community for use with their patients.

Forward-Looking Statements: Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.

Contact Information